Endpoints News 4. Dez. 2025 BioNexus gets $500M to step into manufacturing; Thermo Fisher, AtomVie expand
Endpoints News 4. Dez. 2025 Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen
Endpoints News 4. Dez. 2025 Clinical trials tech startup Paradigm raises $78M, acquires part of Roche’s Flatiron
Endpoints News 3. Dez. 2025 FDA to name Tracy Beth Høeg, who helped lead Covid-shot investigation, to head CDER
Endpoints News 3. Dez. 2025 Former FDA commissioners slam Prasad's plan for 'sweeping' vaccine changes
Endpoints News 3. Dez. 2025 FDA seeks to raise user fees for companies running Phase 1 trials outside the US
Endpoints News 3. Dez. 2025 FDA says it won't release details of claimed Covid vaccine deaths in 'near term'
Endpoints News 3. Dez. 2025 With Phase 3 Duchenne success, Capricor plots path forward after FDA rejection
Endpoints News 3. Dez. 2025 Black Diamond reports mid-stage lung cancer data, continues its hunt for a partner
Endpoints News 3. Dez. 2025 Excelsior Sciences raises $95M for small molecule drug discovery, manufacturing
Endpoints News 3. Dez. 2025 Bristol Myers pushes back Cobenfy readout after trial site 'irregularities'